Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival.
Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival.
复制标题
谷氨酸代谢受体在肾细胞癌风险和生存中的临床意义。
DOI:
10.1002/cam4.1901
复制
发表时间:
2018-12
期刊:
影响因子:
4
通讯作者:
Bao BY
中科院分区:
文献类型:
--
作者:
Huang CY;Hsueh YM;Chen LC;Cheng WC;Yu CC;Chen WJ;Lu TL;Lan KJ;Lee CH;Huang SP;Bao BY
Accumulating evidence suggests the roles of glutamate metabotropic receptors (GRMs) in cancer, in addition to synaptic signalling. The present study assessed the associations of genetic variants in eight GRM genes with regard to risk and overall survival (OS) in 780 renal cell carcinoma (RCC) patients and controls. After adjustment for known risk factors, GRM5 rs7102764 T was associated with an increased risk of RCC (P = 0.006). Additional analysis has provided evidence that rs7102764 T was correlated with a higher expression of GRM5, which is consistently found to be upregulated in tumours, compared to normal tissues. Furthermore, the GRM3 rs701332 C, GRM4 rs2499707 T, and GRM4 rs4713742 T alleles were significantly associated with a poorer OS (P ≤ 0.030). The three loci were also observed to have strong cumulative effects on OS. Additional analysis has revealed a significant genotype‐expression correlation of rs2499707 T with increased GRM4 expression, which in turn leads to poorer OS in patients with RCC. GRMs might be involved in RCC development and progression, and genetic variants in GRMs might be promising biomarkers.
登录
查看更多内容
影响因子:
2.8
作者:
Pang Y;Zhao J;Fowdur M;Liu Y;Wu H;He M
通讯作者:
He M
影响因子:
3.7
作者:
Liao S;Ruiz Y;Gulzar H;Yelskaya Z;Ait Taouit L;Houssou M;Jaikaran T;Schvarts Y;Kozlitina K;Basu-Roy U;Mansukhani A;Mahajan SS
通讯作者:
Mahajan SS
影响因子:
14.9
作者:
Chung IF;Chen CY;Su SC;Li CY;Wu KJ;Wang HW;Cheng WC
通讯作者:
Cheng WC
影响因子:
6.6
作者:
Huang, Chao-Yuan;Chu, Jan-Show;Hsueh, Yu-Mei
通讯作者:
Hsueh, Yu-Mei
影响因子:
14.9
作者:
Xu Z;Taylor JA
通讯作者:
Taylor JA